It is a symbolic first step.
Launched at the beginning of the year, the giant fund to support French flagships listed on the stock exchange has just made its first investment.
Called “Lac 1”, it acquired a 5.08% stake in the capital of French chemist Arkema, for an amount of 348 million euros.
The investment fund, managed by the public investment bank Bpifrance, plans to increase its participation in the capital of the specialist in specialty chemicals.
And Bpifrance should obtain a seat on the board of directors at the next general meeting in May.
Read also:
Arkema refocuses on specialty materials
The strike force of "Lac 1" is very important.
The fund currently has 4.2 billion euros and aims to achieve an investment capacity of 10 billion euros.
At the start of the year, in addition to Bpifrance, around twenty investors took part in the first capital raising: several large institutional investors (insurance companies, banks), the Orange groups, Unibel, Financière
This article is for subscribers only.
You have 67% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
Enter your email
Already subscribed?
Log in
